Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment

BACKGROUND: The aim of this study was to investigate the role of human epidermal growth factor receptor (HER3) and PTEN expression in patients with HER2-overexpressing metastatic breast cancer (MBC). METHODS: One hundred twenty-five MBC patients who were treated with taxane plus trastuzumab chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Y H, Jung, H A, Choi, M K, Chang, W, Choi, Y L, Do, I-g, Ahn, J S, Im, Y-H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899777/
https://www.ncbi.nlm.nih.gov/pubmed/24346286
http://dx.doi.org/10.1038/bjc.2013.757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899777/
https://www.ncbi.nlm.nih.gov/pubmed/24346286
http://dx.doi.org/10.1038/bjc.2013.757

Ejemplares similares